Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (4): 248-251.
Previous Articles Next Articles
ZHANG Jing, CHU Mingming, LI Letao, ZHANG Rong*
Received:
2019-05-09
Revised:
2019-05-09
Online:
2019-04-20
Published:
2019-05-09
CLC Number:
ZHANG Jing, CHU Mingming, LI Letao, ZHANG Rong. One Case of Epileptic Seizure Induced by Increased Blood Concentration of Cyclosporine Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(4): 248-251.
Add to citation manager EndNote|Ris|BibTeX
[1] 曲彩红, 苏向阳. 伏立康唑致环孢素血药浓度升高相关癫痫样发作[J]. 药物不良反应杂志, 2010, 12(5):354-356. [2] 江灏, 陈英, 何菊英. 1例纯红细胞再生障碍性贫血患者出现癫痫发作的药源性因素分析[J]. 中国药物应用与监测, 2013, 10(3):181-182. [3] Gaggero R, Haupt R, Fondelli M P, et al.Intractable Epilepsy Secondary to Cyclosporine Toxicity in Children Undergoing Allogeneic Hematopoietic Bone Marrow Transplantation[J]. Journal of Child Neurology, 2006, 21(10):861-866. [4] Vesole A S, Nagahama Y, Granner M A, et al.Drug-resistant epilepsy development following stem cell transplant and cyclosporine neurotoxicity induced seizures: Case report in an adult and analysis of reported cases in the literature[J]. Epilepsy and Behavior Case Reports, 2018, 10:8-13. [5] 李瑞莲, 陈文倩, 张丹, 等. 154例肾病综合征患者环孢素A血药浓度监测及其对疗效、安全性的影响分析[J]. 中国药房, 2018, 29(20):2827-2831. [6] 毕晓莹, 陶沂. 环孢霉素的神经系统毒性[J]. 国际神经病学神经外科学杂志, 2004, 31(6):519-522. [7] 赖针珍. 环孢素致可逆性后部白质脑病综合征1例[J]. 中国乡村医药, 2018, 25(15):38. [8] 吴鹏辉, 谢瑶, 赵卫红, 等. 血液病/肿瘤患儿并发可逆性后部白质脑病综合征[J]. 北京大学学报(医学版), 2018, 50(4):662-665. [9] Valldeoriola F, Graus F, Rimola A, et al.Cyclosporine-associated mutism in liver transplant patients[J]. Neurology, 1996, 46(1):252-254. [10] 韦恩. 药物相互作用原理与临床应用指南[M]. 人民军医出版社,2011. [11] 刘振威, 胡卓汉, 蔡映云. 异烟肼和利福平联合用药对健康成人原代肝细胞CYP450同工酶1A2和3A4活性的影响[J]. 中华结核和呼吸杂志, 2005, 28(11):785-788. [12] Florea N R, Capitano B, Nightingale C H, et al.Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients[J]. Transplantation Proceedings, 2003, 35(8):2873-2877. [13] Gerntholtz T, Pascoe M D, Botha J F, et al.The use of a cyclosporin-ketoconazole combination: Making renal transplantation affordable in developing countries[J]. European Journal of Clinical Pharmacology, 2004, 60(3):143-148. [14] Iyengar A, Kamath N, Phadke K, et al.Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome[J]. Indian Journal of Nephrology, 2013, 23(6):419-423. [15] 易林高, 吴明钗, 黄鹏, 等. HPLC/MS测定环孢素A单用及联用氟康唑的血药浓度[J]. 中国药物应用与监测, 2016, 13(4):211-213. [16] Valenzuela R, Torres J P, Salas C, et al.Drug interaction of voriconazole-cyclosporine in children undergoing hematopoietic stem cell transplantation (2013-2014)[J]. Rev Chilena Infectol, 2017, 34(1):14-18. [17] Masoumi H T, Hadjibabaie M, Vaezi M, et al.Evaluation of the Interaction of Intravenous and Oral Voriconazole with Oral Cyclosporine in Iranian HSCT Patients[J]. Journal of Research in Pharmacy Practice, 2017, 6(2):77-82. [18] Ishiwata Y, Nagata M, Arai T, et al.Effects of miconazole oral gel on blood concentrations of tacrolimus and cyclosporine: a retrospective observational study[J]. Therapeutic Drug Monitoring, 2016, 38(6):717-721. [19] Romero A.Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients[J]. Clinical Pharmacology & Therapeutics, 2002, 71(4):226-234. [20] 丁春雷, 孙健姿, 张熠, 等. 环孢素浓度异常升高致高尿酸血症1例[J]. 中国药物警戒, 2011, 8(3):190-190. [21] Yang T, Wu X M, Qiu H Q, et al.Adverse drug interactions as a high-risk factor for lethal post-transplant complications in Chinese population[J]. Clinical Transplantation, 2013, 27(2):255-260. |
[1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
[2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
[3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
[4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
[5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
[6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
[7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
[8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
[9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
[10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
[11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
[12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
[13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
[14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
[15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||